Deep Track Capital’s Olema Pharmaceuticals OLMA Stock Holding History

Deep Track Capital’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.8M	Buy	+1,500,000	New	+$20.1M	0.27%	58
2025 Q4	–	Sell	-3,470,172	Closed	-$34M	–	67
2025 Q3	$34M	Buy	3,470,172 +27,339	+0.8%	+$164K	0.95%	31
2025 Q2	$14.7M	Hold	3,442,833	–	–	0.47%	41
2025 Q1	$12.9M	Hold	3,442,833	–	–	0.42%	47
2024 Q4	$20.1M	Sell	3,442,833 -557,167	-14%	-$5.56M	0.75%	36
2024 Q3	$47.8M	Hold	4,000,000	–	–	1.51%	23
2024 Q2	$43.3M	Buy	4,000,000 +774,581	+24%	+$8.4M	1.29%	30
2024 Q1	$36.5M	Buy	3,225,419 +1,294,525	+67%	+$16.7M	1.05%	38
2023 Q4	$27.1M	Hold	1,930,894	–	–	0.9%	41
2023 Q3	$23.8M	Buy	+1,930,894	New	+$19.7M	0.92%	33

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Deep Track Capital's OLMA Position: Q2 2026 in Review

Deep Track Capital opened a new position in Olema Pharmaceuticals (OLMA) in Q2 2026: 1,500,000 shares worth $18.8M. The stake represents 0.27% of the portfolio and ranks #58 among its holdings. This is a return to the name: Deep Track Capital previously reported a position in OLMA as recently as Q3 2025.

Deep Track Capital first reported a position in OLMA in Q3 2023 and has held it in 10 quarters since. The position peaked at $47.8M in Q3 2024. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Deep Track Capital held 1,500,000 shares of Olema Pharmaceuticals worth $18.8M as of Q2 2026.
Olema Pharmaceuticals was a new Deep Track Capital position in Q2 2026.
Olema Pharmaceuticals made up 0.27% of Deep Track Capital's portfolio in Q2 2026, its #58 holding.
Deep Track Capital first reported a position in Olema Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
Deep Track Capital's Olema Pharmaceuticals position peaked at $47.8M in Q3 2024.
186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.